Ozdas Asli, Speroff Theodore, Waitman L Russell, Ozbolt Judy, Butler Javed, Miller Randolph A
Department of Biomedical Informatics, Vanderbilt University, Nashville, TN, USA.
J Am Med Inform Assoc. 2006 Mar-Apr;13(2):188-96. doi: 10.1197/jamia.M1656. Epub 2005 Dec 15.
In the context of an inpatient care provider order entry (CPOE) system, to evaluate the impact of a decision support tool on integration of cardiology "best of care" order sets into clinicians' admission workflow, and on quality measures for the management of acute myocardial infarction (AMI) patients.
A before-and-after study of physician orders evaluated (1) per-patient use rates of standardized acute coronary syndrome (ACS) order set and (2) patient-level compliance with two individual recommendations: early aspirin ordering and beta-blocker ordering.
The effectiveness of the intervention was evaluated for (1) all patients with ACS (suspected for AMI at the time of admission) (N = 540) and (2) the subset of the ACS patients with confirmed discharge diagnosis of AMI (n = 180) who comprise the recommended target population who should receive aspirin and/or beta-blockers. Compliance rates for use of the ACS order set, aspirin ordering, and beta-blocker ordering were calculated as the percentages of patients who had each action performed within 24 hours of admission.
For all ACS admissions, the decision support tool significantly increased use of the ACS order set (p = 0.009). Use of the ACS order set led, within the first 24 hours of hospitalization, to a significant increase in the number of patients who received aspirin (p = 0.001) and a nonsignificant increase in the number of patients who received beta-blockers (p = 0.07). Results for confirmed AMI cases demonstrated similar increases, but did not reach statistical significance.
The decision support tool increased optional use of the ACS order set, but room for additional improvement exists.
在住院医疗服务提供者医嘱录入(CPOE)系统的背景下,评估决策支持工具对将心脏病“最佳治疗”医嘱集整合到临床医生入院工作流程中的影响,以及对急性心肌梗死(AMI)患者管理质量指标的影响。
一项对医生医嘱的前后对照研究,评估(1)标准化急性冠状动脉综合征(ACS)医嘱集的患者使用率,以及(2)患者层面对于两项单独建议的依从性:早期开具阿司匹林医嘱和β受体阻滞剂医嘱。
针对以下两类患者评估干预措施的有效性:(1)所有ACS患者(入院时疑似AMI)(N = 540),以及(2)确诊出院诊断为AMI的ACS患者子集(n = 180),这些患者是应接受阿司匹林和/或β受体阻滞剂治疗的推荐目标人群。ACS医嘱集的使用、阿司匹林医嘱开具和β受体阻滞剂医嘱开具的依从率计算为在入院24小时内执行每项操作的患者百分比。
对于所有ACS入院患者,决策支持工具显著提高了ACS医嘱集的使用率(p = 0.009)。在住院的头24小时内,使用ACS医嘱集使接受阿司匹林治疗的患者数量显著增加(p = 0.001),而接受β受体阻滞剂治疗的患者数量增加不显著(p = 0.07)。确诊AMI病例的结果显示出类似的增加,但未达到统计学显著性。
决策支持工具增加了ACS医嘱集的选择性使用,但仍有进一步改进的空间。